Seres Therapeutics

About:

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

Website: http://www.serestherapeutics.com

Twitter/X: SeresTX

Top Investors: RA Capital Management, Sofinnova Investments, Mayo Clinic, Oaktree Capital Management, CARB-X

Description:

Seres Therapeutics is a clinical-stage biotherapeutic company that develops ecobiotic therapeutic products. They engaged in developing biological drugs which are referred to as ecobiotic microbiome therapeutics. The company is a group of experts in microbiome research and drug development. Its executive team, board of directors, and scientific advisory board have a wealth of experience in the development, regulatory approval, and profitable commercialization of a wide range of therapeutic products.

Total Funding Amount:

$538M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)serestherapeutics.com

Founders:

David Berry, Geoffrey von Maltzahn, Noubar Afeyan

Number of Employees:

101-250

Last Funding Date:

2023-04-27

IPO Status:

Public

© 2025 bioDAO.ai